Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responses -н Pushparaj, P, Nicoletto, A, Castro Dopico, X, Sheward, DJ, Kim, S, Ekström, S, Murrell, B, Corcoran, M, Karlsson Hedestam, GB

Immunoglobulin germline gene polymorphisms influence the function of SARS-CoV-2 neutralizing antibodies -н Pushparaj, P, Nicoletto, A, Sheward, DJ, Das, H, Castro Dopico, X, Perez Vidakovics, L, Hanke, L, Chernyshev, M, Narang, S, Kim, S, Fischbach, J, Ekström, S, McInerney, G, Hällberg, BM, Murrell, B, Corcoran, M, Karlsson Hedestam, GB

Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies -н Sheward, DJ, Pushparaj, P, Das, H, Greaney, AJ, Kim, C, Kim, S, Hanke, L, Hyllner, E, Dyrdak, R, Lee, J, Dopico, XC, Dosenovic, P, Peacock, TP, McInerney, GM, Albert, J, Corcoran, M, Bloom, JD, Murrell, B, Karlsson Hedestam, GB, Hällberg, BM

Multi-compartmental diversification of neutralizing antibody lineages dissected in SARS-CoV-2 spike-immunized macaques -н Mandolesi, M, Das, H, de Vries, L, Yang, Y, Kim, C, Dhinakaran, M, Castro Dopico, X, Fischbach, J, Kim, S, Guryleva, MV, Àdori, M, Chernyshev, M, Stålmarck, A, Hanke, L, McInerney, GM, Sheward, DJ, Corcoran, M, Hällberg, BM, Murrell, B, Karlsson Hedestam, GB